Inphi Stock Price, Forecast & Analysis (NYSE:IPHI)

Inphi trades on the New York Stock Exchange (NYSE) under the ticker symbol "IPHI."

Inphi Co. (NYSE:IPHI) released its quarterly earnings results on Tuesday, October, 29th. The semiconductor company reported $0.45 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.37 by $0.08. The semiconductor company had revenue of $94.23 million for the quarter, compared to the consensus estimate of $90.09 million. Inphi had a negative net margin of 23.23% and a positive return on equity of 0.46%. Inphi's revenue was up 20.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.30 earnings per share. View Inphi's Earnings History.

Inphi is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Inphi.

Inphi updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided earnings per share guidance of $0.40-0.50 for the period, compared to the Thomson Reuters consensus estimate of $0.43. The company issued revenue guidance of $97.8-101.8 million, compared to the consensus revenue estimate of $95.35 million.

14 equities research analysts have issued 1 year price objectives for Inphi's shares. Their forecasts range from $45.00 to $95.00. On average, they expect Inphi's stock price to reach $71.00 in the next year. This suggests a possible upside of 2.7% from the stock's current price. View Analyst Price Targets for Inphi.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inphi in the last year. There are currently 1 sell rating, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Inphi.

News coverage about IPHI stock has been trending positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Inphi earned a news sentiment score of 3.0 on InfoTrie's scale. They also gave media headlines about the semiconductor company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Inphi.

Inphi saw a drop in short interest in October. As of October 31st, there was short interest totalling 4,560,000 shares, a drop of 13.6% from the September 30th total of 5,280,000 shares. Based on an average daily trading volume, of 924,000 shares, the short-interest ratio is presently 4.9 days. Approximately 10.3% of the shares of the company are sold short. View Inphi's Current Options Chain.

Some companies that are related to Inphi include Intel (INTC), NVIDIA (NVDA), Broadcom (AVGO), Texas Instruments (TXN), Micron Technology (MU), Analog Devices (ADI), Xilinx (XLNX), Microchip Technology (MCHP), Marvell Technology Group (MRVL), Skyworks Solutions (SWKS), Maxim Integrated Products (MXIM), Cypress Semiconductor (CY), Monolithic Power Systems (MPWR), First Solar (FSLR) and Cree (CREE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Inphi investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), CVS Health (CVS), Veeva Systems (VEEV), Cisco Systems (CSCO), Micron Technology (MU), QUALCOMM (QCOM), Skyworks Solutions (SWKS) and Intel (INTC).

Inphi's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Stephens Investment Management Group LLC (0.53%), Kornitzer Capital Management Inc. KS (0.35%), Columbus Circle Investors (0.29%), Scout Investments Inc. (0.24%), California Public Employees Retirement System (0.23%) and Lisanti Capital Growth LLC (0.15%). Company insiders that own Inphi stock include Charles Roach, Diosdado P Banatao, Ford Tamer, John Edmunds, Nicholas Brathwaite, Richard Ogawa, Ron Torten, Sam Srinivasan and William J Ruehle. View Institutional Ownership Trends for Inphi.

IPHI stock was sold by a variety of institutional investors in the last quarter, including Alexandria Capital LLC, Taylor Frigon Capital Management LLC, Stephens Investment Management Group LLC, Virginia Retirement Systems ET AL, First Trust Advisors LP, WCM Investment Management LLC, Scout Investments Inc. and Empowered Funds LLC. Company insiders that have sold Inphi company stock in the last year include Charles Roach, Diosdado P Banatao, Ford Tamer, John Edmunds, Nicholas Brathwaite, Richard Ogawa, Ron Torten, Sam Srinivasan and William J Ruehle. View Insider Buying and Selling for Inphi.

IPHI stock was purchased by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Lisanti Capital Growth LLC, California Public Employees Retirement System, State of New Jersey Common Pension Fund D, Delta Investment Management LLC, Sepio Capital LLC, Kornitzer Capital Management Inc. KS and Coronation Fund Managers Ltd.. Company insiders that have bought Inphi stock in the last two years include Ford Tamer and Sam Srinivasan. View Insider Buying and Selling for Inphi.

Shares of IPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IPHI stock can currently be purchased for approximately $69.12.

Inphi has a market capitalization of $3.16 billion and generates $294.49 million in revenue each year. The semiconductor company earns $-95,750,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. Inphi employs 580 workers across the globe.View Additional Information About Inphi.

The official website for Inphi is http://www.inphi.com/.

Inphi's mailing address is 2953 Bunker Hill Lane Suite 300, Santa Clara CA, 95054. The semiconductor company can be reached via phone at 408-217-7300 or via email at [email protected]